Neurocrine Biosciences Inc
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 12,324 | 0.0% | 86,891 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 12,973 | 0.0% | 92,414 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 12,450 | 0.0% | 99,053 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 10,777 | 0.0% | 97,443 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 13,301 | 0.0% | 97,443 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 11,238 | 0.0% | 97,533 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 14,226 | 0.0% | 103,333 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 11,078 | 0.0% | 109,446 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 14,137 | 0.0% | 107,293 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 12,060 | 0.0% | 107,197 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 10,095 | 0.0% | 107,047 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 11,078 | 0.0% | 109,446 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 13,072 | 0.0% | 109,446 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 11,803 | 0.0% | 111,126 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 11,069 | 0.0% | 113,556 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 11,498 | 0.0% | 122,641 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 10,455 | 0.0% | 122,751 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 11,829 | 0.0% | 123,333 | 9/30/2021 |
| 2021 Q2 | 8/10/2021 | 12,318 | 0.0% | 126,571 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 14,082 | 0.0% | 144,800 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 14,238 | 0.0% | 148,540 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 13,197 | 0.0% | 137,240 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 16,553 | 0.0% | 135,680 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 10,553 | 0.0% | 121,929 | 3/31/2020 |
| 2019 Q4 | 2/3/2020 | 13,041 | 0.0% | 121,323 | 12/31/2019 |
| 2014 Q2 | 8/7/2014 | 1,045 | 0.0% | 70,441 | 6/30/2014 |
| 2014 Q1 | 4/24/2014 | 993 | 0.0% | 61,669 | 3/31/2014 |
| 2013 Q4 | 2/5/2014 | 576 | 0.0% | 61,669 | 12/31/2013 |